SEP 24, 2020 7:30 AM PDT

2-In-1: Stroke Scans Also Diagnose COVID

WRITTEN BY: Tara Fernandez

King’s College London researchers took a closer look at emergency room CT scans of patients suspected of having a stroke and made a surprising discovery: the scans could also be used to indicate the presence of COVID-19 infection.

The study, published in the American Journal of Neuroradiology saw the researchers examining over 200 carotid CTA scans of the blood vessels in the head and neck of patients who were admitted to the stroke unit.

They noticed that in around 20 percent of the scans, the upper regions of the lungs showed ground glass opacity or GGO. This is a term used in radiology to describe the slightly hazy opacity in the respiratory system, indicating that the air spaces in the lungs have partially filled up with fluid.

When put side by side with the COVID-19 diagnostic tests, the authors found that the presence of GGO in CT scans was a solid diagnostic marker of infection, with 75 percent sensitivity and 81 percent specificity. GGO in the lungs was also found to spell bad news for patients, spiking their risk of mortality in the month following the find.

According to the team, this serendipitous finding can limit avoidable exposures of hospital staff to infected patients.

“The implications of our findings plausibly include the earlier selection of the appropriate level of personal protective equipment and attendant staff numbers, triage to appropriate inpatient ward settings, self-isolation, and contact tracing,” the team explained. 

“Biomarkers, such as a scan positive for GGO, should heighten awareness of a potential positive case, possibly changing staff personal protective equipment requirements and also directing a patient to a side room instead of an open ward, pending RT-PCR results.”

 

 

Sources: Diagnostic Imaging, American Journal of Neuroradiology.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
JUN 30, 2020
Cardiology
Investigating How Aging Affects Cardiac Health in Marmosets
JUN 30, 2020
Investigating How Aging Affects Cardiac Health in Marmosets
Age is something that scientists still struggle to understand. It seems to be built into the DNA and affects the human b ...
JUL 30, 2020
Clinical & Molecular DX
Laser Beams Vibrate Viruses to Distinguish Them
JUL 30, 2020
Laser Beams Vibrate Viruses to Distinguish Them
  In light of the ongoing COVID-19 pandemic, the importance of rapid viral diagnostics has really hit home. Classic ...
SEP 01, 2020
Clinical & Molecular DX
Scalp Implants Monitor Epileptic Seizures
SEP 01, 2020
Scalp Implants Monitor Epileptic Seizures
Neuroscientists have developed devices that, when implanted under the scalp of individuals living with epilepsy, can mon ...
SEP 09, 2020
Clinical & Molecular DX
Swallow the Pill, Discover the Bugs Within
SEP 09, 2020
Swallow the Pill, Discover the Bugs Within
The 30-foot long human gastrointestinal tract consists of tissues and organs that work in concert to digest our food. Th ...
SEP 07, 2020
Cell & Molecular Biology
With Nanopores, Small Samples Detect Diseases
SEP 07, 2020
With Nanopores, Small Samples Detect Diseases
If you've ever been through a battery of tests while doctors try to find a diagnosis for an ailment, you know that many ...
SEP 17, 2020
Clinical & Molecular DX
Blood Vessels on a Chip Test Clotting
SEP 17, 2020
Blood Vessels on a Chip Test Clotting
Blood clotting, also known as coagulation, is a critical biological mechanism to prevent excessive blood loss in the eve ...
Loading Comments...